How Often Should Part D's Model Formulary Be Revised? USP And CMS Disagree
Executive Summary
In releasing its first revisions to the model guidelines for Medicare Part D formularies since 2008, the U.S. Pharmacopeia advocates that returning to an annual review cycle would better serve patients.
You may also be interested in...
USP Formulary Guidelines Back In Spotlight With Essential Health Benefits Proposal
HHS proposes to use USP’s drug classification system, created as a guideline for Medicare Part D formularies, to facilitate “review, analysis and comparison” of the breadth of drug coverage offered by individual and small group private insurance plans beginning in 2014.
USP's Part D Formulary Guidelines Add 38 Unique Drug Categories/Classes
In an effort to make a more usable two-tiered model guideline for Medicare Part D formularies, USP proposed 38 more unique categories and classes in its version 5 model guidelines compared to version 4.